SAHPRA Approves Pfizer’s Paxlovid COVID-1...

By Staff Writer

January 30, 2023

SAHPRA announced the registration of Paxlovid COVID-19 treatment, an anti-viral medicine manufactured by Pfizer, to treat COVID-1...
Surgical Repair vs. Non-Surgical Treatment for Rotator Cuff Tears: Is Surgery...
Biosimilar uptake in public hospitals: NHS Hospitals
Amputations under PMB Regulations: The Latest CMScript
Gathering and analyzing patient experience data in a real-world setting is a ...
ISPOR Releases Top 10 HEOR Trends Report for 2022-2023
Abu Dhabi Launches Drug and Poison Information Service to Improve Healthcare ...